Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group
Rea, Delphine, Ame, Shanti, Berger, Marc, Cayuela, Jean‐Michel, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Dubruille, Viviane, Dulucq, Stéphanie, Etienne, Gabriel, Legros, Laurence, Nicolini, Franck, Roche‐Lestienne, Catherine, Escoffre‐Barbe, Martine, Gardembas, Martine, Guerci‐Bresler, Agnès, Johnson‐Ansah, Hyacinthe, Rigal‐Huguet, Françoise, Rousselot, Philippe, Mahon, François‐Xavier
Published in Cancer (15.07.2018)
Published in Cancer (15.07.2018)
Get full text
Journal Article
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome
Berger, Marc G., Pereira, Bruno, Rousselot, Philippe, Cony‐Makhoul, Pascale, Gardembas, Martine, Legros, Laurence, Escoffre‐Barbe, Martine, Nicolini, Franck‐Emmanuel, Saugues, Sandrine, Lambert, Céline, Réa, Delphine, Guerci‐Bresler, Agnès, Giraudier, Stéphane, Guilhot, Joëlle, Saussele, Susanne, Mahon, François‐Xavier
Published in British journal of haematology (01.11.2019)
Published in British journal of haematology (01.11.2019)
Get full text
Journal Article
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM)
Jouzier, Claire, Cherait, Amina, Cony‐Makhoul, Pascale, Hamel, Jean‐François, Veloso, Melanie, Thepot, Sylvain, Cluzeau, Thomas, Stamatoullas, Aspasia, Garnier, Alice, Guerci‐Bresler, Agnès, Dimicoli‐Salazar, Sophie, Pica, Gian Matteo, Cheze, Stéphane, Santana, Clémence, Chermat, Fatiha, Fenaux, Pierre, Park, Sophie
Published in Transfusion (Philadelphia, Pa.) (01.05.2022)
Published in Transfusion (Philadelphia, Pa.) (01.05.2022)
Get full text
Journal Article
Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study)
Roy, Lydia, Chomel, Jean‐Claude, Guilhot, Joëlle, Guerci‐Bresler, Agnès, Escoffre‐Barbe, Martine, Giraudier, Stéphane, Charbonnier, Aude, Dubruille, Viviane, Huguet, Françoise, Johnson‐Ansah, Hyacinthe, Lenain, Pascal, Ame, Shanti, Etienne, Gabriel, Nicolini, Franck E., Rea, Delphine, Cony‐Makhoul, Pascale, Courby, Stéphane, Ianotto, Jean‐Christophe, Legros, Laurence, Machet, Antoine, Coiteux, Valérie, Hermet, Eric, Cayssials, Emilie, Bouchet, Stéphane, Mahon, Francois‐Xavier, Rousselot, Philippe, Guilhot, François
Published in British journal of haematology (01.01.2023)
Published in British journal of haematology (01.01.2023)
Get full text
Journal Article
Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials
Roy, Lydia, Guilhot, Joëlle, Krahnke, Tillmann, Guerci-Bresler, Agnès, Druker, Brian J., Larson, Richard A., O'Brien, Steve, So, Charlene, Massimini, Giorgio, Guilhot, François
Published in Blood (01.09.2006)
Published in Blood (01.09.2006)
Get full text
Journal Article
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+CD15− cells in early chronic‐phase chronic myeloid leukemia
Maupetit‐Mehouas, Stéphanie, Court, Franck, Bourgne, Céline, Guerci‐Bresler, Agnès, Cony‐Makhoul, Pascale, Johnson, Hyacinthe, Etienne, Gabriel, Rousselot, Philippe, Guyotat, Denis, Janel, Alexandre, Hermet, Eric, Saugues, Sandrine, Berger, Juliette, Arnaud, Philippe, Berger, Marc G.
Published in Molecular oncology (01.06.2018)
Published in Molecular oncology (01.06.2018)
Get full text
Journal Article
A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM)
Ades, Lionel, Guerci-Bresler, Agnès, Cony-Makhoul, Pascale, Legros, Laurence, Sebert, Marie, Braun, Thorsten, Delaunay, Jacques, Desseaux, Kristell, Chevret, Sylvie, Fenaux, Pierre
Published in Haematologica (Roma) (01.04.2019)
Published in Haematologica (Roma) (01.04.2019)
Get full text
Journal Article
Impact of ELN recommendations in the management of first‐line treated chronic myeloid leukaemia patients: a French cross‐sectional study
Etienne, Gabriel, Huguet, Francoise, Guerci‐Bresler, Agnès, Nicolini, Franck E., Maloisel, Frédéric, Coiteux, Valérie, Dauriac, Charles, Carpentier, Nathalie, Bourdeix, Isabelle, Tulliez, Michel, Cony‐Makhoul, Pascale
Published in British journal of haematology (01.07.2016)
Published in British journal of haematology (01.07.2016)
Get full text
Journal Article
Using healthcare claims data to analyze the prevalence of BCR‐ABL‐positive chronic myeloid leukemia in France: A nationwide population‐based study
Foulon, Stéphanie, Cony‐Makhoul, Pascale, Guerci‐Bresler, Agnès, Delord, Marc, Solary, Eric, Monnereau, Alain, Bonastre, Julia, Tubert‐Bitter, Pascale
Published in Cancer medicine (Malden, MA) (01.06.2019)
Published in Cancer medicine (Malden, MA) (01.06.2019)
Get full text
Journal Article
Efficacy of lenalidomide in myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and an extreme platelet count
Divoux, Marion, Plocque, Alexia, Sevin, Margaux, Voillat, Laurent, Feugier, Pierre, Guerci‐Bresler, Agnès, Girodon, Francois, Broséus, Julien
Published in Clinical case reports (01.09.2020)
Published in Clinical case reports (01.09.2020)
Get full text
Journal Article
Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies
ADES, Lionel, LE BRAS, Fabien, TURLURE, Pascal, GUERCI BRESLER, Agnès, CABROL, Marie-Paule, BANOS, Anne, BLANC, Michel, VEY, Norbert, DELMER, Alain, WATTEL, Eric, CHEVRET, Sylvie, FENAUX, Pierre, SEBERT, Marie, KELAIDI, Charikleia, LAMY, Thierry, DREYFUS, François, ECLACHE, Virginie, DELAUNAY, Jacques, BOUSCARY, Didier, VISANICA, Sorin
Published in Haematologica (Roma) (01.02.2012)
Published in Haematologica (Roma) (01.02.2012)
Get full text
Journal Article
Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM
Natarajan-Amé, Shanti, Park, Sophie, Ades, Lionel, Vey, Norbert, Guerci-Bresler, Agnès, Cahn, Jean-Yves, Etienne, Gabriel, Bordessoule, Dominique, Ravoet, Christophe, Legros, Laurence, Cheze, Stephane, Stamatoullas, Aspasia, Berger, Elisabeth, Schmidt, Aline, Charbonnier, Aude, Chaury, Marie-Pierre, Braun, Thorsten, Fenaux, Pierre, Dreyfus, Francois
Published in British journal of haematology (01.07.2012)
Published in British journal of haematology (01.07.2012)
Get full text
Journal Article
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study
Rea, Delphine, Nicolini, Franck E., Tulliez, Michel, Guilhot, François, Guilhot, Joelle, Guerci-Bresler, Agnès, Gardembas, Martine, Coiteux, Valérie, Guillerm, Gaelle, Legros, Laurence, Etienne, Gabriel, Pignon, Jean-Michel, Villemagne, Bruno, Escoffre-Barbe, Martine, Ianotto, Jean-Christophe, Charbonnier, Aude, Johnson-Ansah, Hyacinthe, Noel, Marie-Pierre, Rousselot, Philippe, Mahon, François-Xavier
Published in Blood (16.02.2017)
Published in Blood (16.02.2017)
Get full text
Journal Article
Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease
ROUSSELOT, Philippe, CHARBONNIER, Aude, ESCOFFRE-BARBE, Martine, GUERCI-BRESLER, Agnès, TULLIEZ, Michel, PROST, Stéphane, SPENTCHIAN, Marc, CAYUELA, Jean Michel, REIFFERS, Josy, CHOMEL, Jean Claude, TURHAN, Ali, GUILHOT, Joëlle, CONY-MAKHOUL, Pascale, GUILHOT, François, MAHON, François-Xavier, AGAPE, Philippe, NICOLINI, Franck E, VARET, Bruno, GARDEMBAS, Martine, ETIENNE, Gabriel, REA, Delphine, ROY, Lydia
Published in Journal of clinical oncology (10.02.2014)
Published in Journal of clinical oncology (10.02.2014)
Get full text
Journal Article
Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia
Legros, Laurence, Nicolini, Franck E., Etienne, Gabriel, Rousselot, Philippe, Rea, Delphine, Giraudier, Stéphane, Guerci‐Bresler, Agnès, Huguet, Françoise, Gardembas, Martine, Escoffre, Martine, Ianotto, Jean‐Christophe, Noël, Marie‐Pierre, Varet, Bruno R., Pagliardini, Thomas, Touitou, Irit, Morisset, Stéphane, Mahon, Francois‐Xavier
Published in Cancer (15.11.2017)
Published in Cancer (15.11.2017)
Get full text
Journal Article
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial
Lipton, Jeffrey H, Prof, Chuah, Charles, MD, Guerci-Bresler, Agnès, MD, Rosti, Gianantonio, Prof, Simpson, David, Prof, Assouline, Sarit, MD, Etienne, Gabriel, MD, Nicolini, Franck E, MD, le Coutre, Philipp, Prof, Clark, Richard E, Prof, Stenke, Leif, MD, Andorsky, David, MD, Oehler, Vivian, MD, Lustgarten, Stephanie, PhD, Rivera, Victor M, PhD, Clackson, Timothy, PhD, Haluska, Frank G, MD, Baccarani, Michele, Prof, Cortes, Jorge E, Prof, Guilhot, François, Prof, Hochhaus, Andreas, Prof, Hughes, Timothy, Prof, Kantarjian, Hagop M, Prof, Shah, Neil P, Prof, Talpaz, Moshe, Prof, Deininger, Michael W, Prof
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study
Rea, Delphine, Henry, Guylaine, Khaznadar, Zena, Etienne, Gabriel, Guilhot, François, Nicolini, Franck, Guilhot, Joelle, Rousselot, Philippe, Huguet, Françoise, Legros, Laurence, Gardembas, Martine, Dubruille, Viviane, Guerci-Bresler, Agnès, Charbonnier, Aude, Maloisel, Frédéric, Ianotto, Jean-Christophe, Villemagne, Bruno, Mahon, François-Xavier, Moins-Teisserenc, Hélène, Dulphy, Nicolas, Toubert, Antoine
Published in Haematologica (Roma) (01.08.2017)
Published in Haematologica (Roma) (01.08.2017)
Get full text
Journal Article
Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients
Nicolini, Franck Emmanuel, Dulucq, Stéphanie, Boureau, Lisa, Cony-Makhoul, Pascale, Charbonnier, Aude, Escoffre-Barbe, Martine, Rigal-Huguet, Françoise, Coiteux, Valérie, Varet, Bruno, Dubruille, Viviane, Lenain, Pascal, Rousselot, Philippe, Rea, Delphine, Guerci-Bresler, Agnès, Legros, Laurence, Liu, Jixing, Gardembas, Martine, Ianotto, Jean-Christophe, Turlure, Pascal, Johnson-Ansah, Hyacinthe, Martiniuc, Juliana, Jardel, Henry, Joly, Bertrand, Zunic, Patricia, Henni, Tawfiq, Villemagne, Bruno, Berger, Marc G, Cayssials, Emilie, Guilhot, François, Larosa, Fabrice, Guilhot, Joëlle, Etienne, Gabriel, Mahon, François-Xavier
Published in Clinical cancer research (15.11.2019)
Published in Clinical cancer research (15.11.2019)
Get full text
Journal Article
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory
Saugues, Sandrine, Lambert, Céline, Daguenet, Elisabeth, Ansah, Hyacinthe Johnson, Turhan, Ali, Huguet, Françoise, Guerci-Bresler, Agnès, Tchirkov, Andreï, Hamroun, Dalil, Hermet, Eric, Pereira, Bruno, Berger, Marc G.
Published in Annals of hematology (01.10.2022)
Published in Annals of hematology (01.10.2022)
Get full text
Journal Article
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial
Guilhot, Francois, Rigal-Huguet, Françoise, Guilhot, Joëlle, Guerci-Bresler, Agnès-Paule, Maloisel, Frédéric, Rea, Delphine, Coiteux, Valérie, Gardembas, Martine, Berthou, Christian, Vekhoff, Anne, Jourdan, Eric, Berger, Marc, Fouillard, Loïc, Alexis, Magda, Legros, Laurence, Rousselot, Philippe, Delmer, Alain, Lenain, Pascal, Escoffre Barbe, Martine, Gyan, Emmanuel, Bulabois, Claude-Eric, Dubruille, Viviane, Joly, Bertrand, Pollet, Bertrand, Cony-Makhoul, Pascale, Johnson-Ansah, Hyacinthe, Mercier, Melanie, Caillot, Denis, Charbonnier, Aude, Kiladjian, Jean-Jacques, Chapiro, Jacques, Penot, Amélie, Dorvaux, Véronique, Vaida, Iona, Santagostino, Alberto, Roy, Lydia, Zerazhi, Hacene, Deconinck, Eric, Maisonneuve, Herve, Plantier, Isabelle, Lebon, Delphine, Arkam, Yazid, Cambier, Nathalie, Ghomari, Kamel, Miclea, Jean-Michel, Glaisner, Sylvie, Cayuela, Jean-Michel, Chomel, Jean-Claude, Muller, Marc, Lhermitte, Ludovic, Delord, Marc, Preudhomme, Claude, Etienne, Gabriel, Mahon, François-Xavier, Nicolini, Franck-Emmanuel
Published in Leukemia (01.08.2021)
Published in Leukemia (01.08.2021)
Get full text
Journal Article